Annual EBIT
-$7.63 M
+$112.13 M+93.63%
December 31, 2023
Summary
- As of February 12, 2025, MGNX annual earnings before interest & taxes is -$7.63 million, with the most recent change of +$112.13 million (+93.63%) on December 31, 2023.
- During the last 3 years, MGNX annual EBIT has risen by +$123.43 million (+94.18%).
- MGNX annual EBIT is now -192.97% below its all-time high of $8.21 million, reached on December 31, 2012.
Performance
MGNX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$56.31 M
+$111.97 M+201.17%
September 30, 2024
Summary
- As of February 12, 2025, MGNX quarterly earnings before interest & taxes is $56.31 million, with the most recent change of +$111.97 million (+201.17%) on September 30, 2024.
- Over the past year, MGNX quarterly EBIT has increased by +$102.38 million (+222.22%).
- MGNX quarterly EBIT is now -46.36% below its all-time high of $104.97 million, reached on December 31, 2017.
Performance
MGNX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$96.48 M
+$38.76 M+28.66%
September 30, 2024
Summary
- As of February 12, 2025, MGNX TTM earnings before interest & taxes is -$96.48 million, with the most recent change of +$38.76 million (+28.66%) on September 30, 2024.
- Over the past year, MGNX TTM EBIT has dropped by -$88.85 million (-1164.79%).
- MGNX TTM EBIT is now -288.27% below its all-time high of $51.24 million, reached on September 30, 2023.
Performance
MGNX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MGNX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +93.6% | +222.2% | -1164.8% |
| 3 y3 years | +94.2% | +184.8% | +55.6% |
| 5 y5 years | +95.5% | +184.8% | +55.6% |
MGNX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.2% | -3.3% | +184.8% | -288.3% | +55.8% |
| 5 y | 5-year | at high | +96.2% | -3.3% | +184.8% | -288.3% | +55.8% |
| alltime | all time | -193.0% | +96.2% | -46.4% | +184.8% | -288.3% | +55.8% |
MacroGenics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $56.31 M(-201.2%) | -$96.48 M(-28.7%) |
| Jun 2024 | - | -$55.66 M(+9.0%) | -$135.23 M(+533.9%) |
| Mar 2024 | - | -$51.06 M(+10.8%) | -$21.33 M(+179.7%) |
| Dec 2023 | -$7.63 M(-93.6%) | -$46.07 M(-362.5%) | -$7.63 M(-114.9%) |
| Sep 2023 | - | $17.55 M(-69.9%) | $51.24 M(+477.2%) |
| Jun 2023 | - | $58.24 M(-255.9%) | $8.88 M(-109.8%) |
| Mar 2023 | - | -$37.35 M(-391.8%) | -$90.67 M(-24.3%) |
| Dec 2022 | -$119.76 M(-40.7%) | $12.80 M(-151.6%) | -$119.76 M(-37.0%) |
| Sep 2022 | - | -$24.81 M(-39.9%) | -$190.12 M(-12.9%) |
| Jun 2022 | - | -$41.30 M(-37.8%) | -$218.29 M(+0.5%) |
| Mar 2022 | - | -$66.44 M(+15.4%) | -$217.26 M(+7.5%) |
| Dec 2021 | -$202.12 M(+54.2%) | -$57.56 M(+8.6%) | -$202.12 M(+37.7%) |
| Sep 2021 | - | -$52.99 M(+31.5%) | -$146.73 M(+13.0%) |
| Jun 2021 | - | -$40.28 M(-21.5%) | -$129.88 M(-5.1%) |
| Mar 2021 | - | -$51.29 M(+2263.7%) | -$136.91 M(+4.5%) |
| Dec 2020 | -$131.06 M(-26.0%) | -$2.17 M(-94.0%) | -$131.06 M(-21.8%) |
| Sep 2020 | - | -$36.13 M(-23.6%) | -$167.54 M(-1.1%) |
| Jun 2020 | - | -$47.31 M(+4.1%) | -$169.35 M(-3.2%) |
| Mar 2020 | - | -$45.45 M(+17.6%) | -$175.01 M(-1.2%) |
| Dec 2019 | -$177.19 M(+3.5%) | -$38.66 M(+1.9%) | -$177.19 M(-1.7%) |
| Sep 2019 | - | -$37.94 M(-28.4%) | -$180.21 M(+1.7%) |
| Jun 2019 | - | -$52.97 M(+11.2%) | -$177.27 M(+5.1%) |
| Mar 2019 | - | -$47.62 M(+14.2%) | -$168.61 M(-1.5%) |
| Dec 2018 | -$171.21 M | -$41.68 M(+19.1%) | -$171.21 M(+597.1%) |
| Sep 2018 | - | -$35.00 M(-21.0%) | -$24.56 M(-34.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$44.31 M(-11.7%) | -$37.28 M(+9.2%) |
| Mar 2018 | - | -$50.21 M(-147.8%) | -$34.14 M(+54.2%) |
| Dec 2017 | -$22.14 M(-63.1%) | $104.97 M(-320.0%) | -$22.14 M(-86.4%) |
| Sep 2017 | - | -$47.72 M(+15.9%) | -$162.35 M(+9.0%) |
| Jun 2017 | - | -$41.18 M(+7.8%) | -$148.89 M(+120.2%) |
| Mar 2017 | - | -$38.21 M(+8.4%) | -$67.62 M(+12.6%) |
| Dec 2016 | -$60.04 M(+197.5%) | -$35.24 M(+2.8%) | -$60.04 M(+12.5%) |
| Sep 2016 | - | -$34.27 M(-185.5%) | -$53.38 M(+54.5%) |
| Jun 2016 | - | $40.09 M(-230.9%) | -$34.56 M(-64.0%) |
| Mar 2016 | - | -$30.63 M(+7.2%) | -$95.95 M(+375.4%) |
| Dec 2015 | -$20.18 M(-47.3%) | -$28.58 M(+85.1%) | -$20.18 M(+90.0%) |
| Sep 2015 | - | -$15.44 M(-27.5%) | -$10.62 M(-1286.6%) |
| Jun 2015 | - | -$21.29 M(-147.2%) | $895.00 K(-91.0%) |
| Mar 2015 | - | $45.13 M(-337.3%) | $9.93 M(-125.9%) |
| Dec 2014 | -$38.31 M(<-9900.0%) | -$19.02 M(+384.2%) | -$38.31 M(+70.3%) |
| Sep 2014 | - | -$3.93 M(-68.0%) | -$22.50 M(+97.1%) |
| Jun 2014 | - | -$12.26 M(+294.5%) | -$11.41 M(-2031.5%) |
| Mar 2014 | - | -$3.11 M(-3.0%) | $591.00 K(+60.9%) |
| Dec 2013 | $366.00 K(-95.5%) | -$3.21 M(-144.8%) | $367.30 K(-72.1%) |
| Sep 2013 | - | $7.16 M(-2918.1%) | $1.32 M(-140.6%) |
| Jun 2013 | - | -$254.00 K(-92.4%) | -$3.24 M(+8.5%) |
| Mar 2013 | - | -$3.33 M(+47.6%) | -$2.99 M(-973.6%) |
| Dec 2012 | $8.21 M(+56.3%) | -$2.26 M(-186.8%) | $342.20 K(-86.8%) |
| Sep 2012 | - | $2.60 M | $2.60 M |
| Dec 2011 | $5.25 M | - | - |
FAQ
- What is MacroGenics annual earnings before interest & taxes?
- What is the all time high annual EBIT for MacroGenics?
- What is MacroGenics annual EBIT year-on-year change?
- What is MacroGenics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MacroGenics?
- What is MacroGenics quarterly EBIT year-on-year change?
- What is MacroGenics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MacroGenics?
- What is MacroGenics TTM EBIT year-on-year change?
What is MacroGenics annual earnings before interest & taxes?
The current annual EBIT of MGNX is -$7.63 M
What is the all time high annual EBIT for MacroGenics?
MacroGenics all-time high annual earnings before interest & taxes is $8.21 M
What is MacroGenics annual EBIT year-on-year change?
Over the past year, MGNX annual earnings before interest & taxes has changed by +$112.13 M (+93.63%)
What is MacroGenics quarterly earnings before interest & taxes?
The current quarterly EBIT of MGNX is $56.31 M
What is the all time high quarterly EBIT for MacroGenics?
MacroGenics all-time high quarterly earnings before interest & taxes is $104.97 M
What is MacroGenics quarterly EBIT year-on-year change?
Over the past year, MGNX quarterly earnings before interest & taxes has changed by +$102.38 M (+222.22%)
What is MacroGenics TTM earnings before interest & taxes?
The current TTM EBIT of MGNX is -$96.48 M
What is the all time high TTM EBIT for MacroGenics?
MacroGenics all-time high TTM earnings before interest & taxes is $51.24 M
What is MacroGenics TTM EBIT year-on-year change?
Over the past year, MGNX TTM earnings before interest & taxes has changed by -$88.85 M (-1164.79%)